menuclose
Home • Specialist • Associate Professor Martin Stiles

Biography

Associate Professor Martin Stiles is an Electrophysiologist based in Waikato, New Zealand. He is the Director of Electrophysiology at Waikato Hospital and an Associate Professor of Medicine at the Waikato Clinical School, University of Auckland.

A/Prof Martin Stiles is passionate about providing high quality, evidence-based care for heart rhythm disorders and promoting equity in health outcomes for New Zealanders. Martin has a particular interest in the diagnosis and treatment of arrhythmia disorders, including inherited cardiac arrhythmia syndromes.

A/Prof Stiles holds fellowships with the Heart Rhythm Society, the Royal Australasian College of Physicians and the Cardiac Society of Australia and New Zealand. In 2009, He completed his PhD on the “Characterisation of the Substrate of Atrial Fibrillation and Flutter” from the University of Adelaide. A/Prof Stiles was also the winner of the Kudos award (Medical Scientist) in 2012 at the Hamilton Science Excellence Awards.

Martin is a keen researcher and has been involved in a plethora of research from bench side experiments to clinical trials. His core research areas include optimising ablation strategies, ICD programming and the investigation of sudden cardiac arrest.

As well as being the Director of Electrophysiology at Waikato Hospital, Martin also consults at Waikato Heart. Associate Professor Martin Stiles has greatly contributed his knowledge and experience through many publications and presentations globally. He was a principal investigator for the REVERSE-AD Dabigatran Reversal Agent multi-centre trial in 2014. He Co-Chaired the International Expert Consensus document for ICD programming in 2015 and is Chairing a similar document on the Investigation of Sudden Cardiac Arrest scheduled for publication in 2020. Martin was part of the expansion of the S-ICD program into Asia as the proctor for the first implantation of this breakthrough defibrillation therapy.

Procedures & Conditions

Procedures Performed
  • Atrial Fibrillation Ablation
  • Atrial Flutter Ablation
  • Atrial Tachycardia Ablation
  • Atrioventricular Node Ablation
  • Biventricular Pacemaker Implantation
  • Cardiac Device Management
  • Cardiac Resynchronisation Therapy
  • Defibrillator Implantation
  • Electrophysiology Studies
  • Event Monitoring
  • Holter Monitoring
  • Implantable Loop Recorder
  • Pacemaker Implantation
  • Pulmonary Vein Cryoablation
  • Pulmonary Vein Isolation
  • Radio Frequency Ablation
  • Subcutaneous ICD Implantation
  • Supraventricular Tachycardia (SVT) Ablation
  • Transvenous ICD Implantation
  • Ventricular Ectopic Ablation
  • Ventricular Tachycardia (VT) Ablation
Conditions Treated
  • Arrhythmia
  • Atrial Fibrillation
  • Atrial Flutter
  • Atrial Tachycardia
  • AV Nodal Re-entry Tachycardia (AVNRT)
  • Bradycardia
  • Brugada Syndrome
  • Complete Heart Block
  • Long QT Syndrome
  • Sick Sinus Syndrome
  • Sinus Node Dysfunction
  • Sudden Cardiac Death
  • Supraventricular Tachycardia (SVT)
  • Syncope
  • Palpitations
  • Ventricular Ectopy
  • Ventricular Tachycardia (VT)
  • Wolff-Parkinson-White Syndrome

Experience

  • Director of Electrophysiology and Cardiologist
    Waikato Hospital 2008 - Present
  • Associate Professor of Medicine
    University of Auckland 2018 - Present
  • Senior Lecturer
    University of Auckland 2008 - 2018
  • Advisory Board
    PHARMAC Cardiovascular 2011 - 2019
  • Electrophysiology Fellow and PhD Candidate
    Royal Adelaide Hospital 2005 - 2008

Memberships & Awards

Professional Memberships and Affiliations
  • Fellow of the Royal Australasian College of Physicians
  • Fellow of the Heart Rhythm Society
  • Fellow of the Cardiac Society of Australia and New Zealand
  • 2017 - PresentChair of Clinical Documents Subcommittee, APHRS
  • 2014 - 2017Chair of Fellowship Subcommittee, APHRS
  • 2011 - 2014Chair of Heart Rhythm NZ
  • 2008 - 2014Board Member of the Asia-Pacific Heart Rhythm Society (APHRS)
Awards
  • 2012Kudos Award (Medical Scientist) - Hamilton Science Excellence Awards

Research & Publications

Publications

1. Bai J, Gladding P, Stiles M, Fedorov V, Zhao J. Ionic and cellular mechanisms underlying TBX5/PITX2 insufficiency-induced atrial fibrillation: Insights from mathematical models of human atrial cells. Scientific Reports, in press

2. Stiles MK, Sanders P, Lau DH. Targeting the Substrate in Ablation of Persistent Atrial Fibrillation: Recent Lessons and Future Directions. Front. Physiol. 2018;9:1158. doi: 10.3389/fphys.2018.01158

3. Xiong Z, Nash MP, Cheng E, Fedorov VV, Stiles MK, Zhao J. ECG signal classification for the detection of cardiac arrhythmias using a convolutional recurrent neural network. Physiol Meas. 2018 doi: 10.1088/1361- 6579/aad9ed

4. Fu X, Liu T, Xiong Z, Smaill BH, Stiles MK, Zhao J. Segmentation of histological images and fibrosis identification with a convolutional neural network. Comput Biol Med. 2018;98:147-158

5. Xiong Z, Liu T, Tse G, Gong M, Gladding PA, Smaill BH, Stiles MK, Gillis AM, Zhao J. A Machine Learning Aided Systematic Review and Meta-Analysis of the Relative Risk of Atrial Fibrillation in Patients with Diabetes Mellitus. Front Physiol. 2018;9:835

6. Webster M, Pasupati S, Lever N, Stiles M. Safety and Feasibility of a Novel Active Fixation Temporary Pacing Lead. J Invasive Cardiol. 2018;30:163-167

7. Lau DH, Thiyagarajah A, Willems S, Rostock T, Linz D, Stiles MK, Kaye D, Kalman JM, Sanders P. Device Therapy for Rate Control: Pacing, Resynchronisation and AV Node Ablation. Heart Lung Circ. 2017;26:934

8. Al Sinan A, Stiles MK. AF ablation: Single shot multielectrode or multishot single electrode? Indian Pacing Electrophysiol J 2017; 17:34

9. Stiles MK. The four pillars of atrial fibrillation management. Research Review 2017 www.researchreview.co.nz/nz/Clinical-Area/GeneralMedicine/General Practice/Speaker-Series-Atrial FibrillationManagement.aspx

10. Gorenek B, Pelliccia A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI, Van Gelder IC, Halle M, Kudaiberdieva G, Lane DA, Larsen TB, Lip GY, Løchen ML, Marín F, Niebauer J, Sanders P, Tokgozoglu L, Vos MA, Van Wagoner DR; Document reviewers: Fauchier L, Savelieva I, Goette A, Agewall S, Chiang CE, Figueiredo M, Stiles M, Dickfeld T, Patton K, Piepoli M, Corra U, Marques-Vidal PM, Faggiano P, Schmid JP, Abreu A. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Europace 2017;19:190-225.

11. Larsen PD, Kerr AJ, Hood M, Harding SA, Hooks D, Heaven D, Lever NA, Sinclair S, Boddington D, Tang EW, Swampillai J, Stiles MK; ANZACS-QI investigators. Pacemaker Use in New Zealand – Data from the New Zealand Implanted Cardiac Device Registry (ANZACS-QI 15). Heart Lung Circ. 2017;26:235-239

12. Zaman S, Taylor AJ, Stiles M, Chow C, Kovoor P. Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction (PROTECTICD): Trial Protocol, Background and Significance. Heart Lung Circ. 2016; 25:1055-1062

13. Earle N, Crawford J, Gibson K, Love D, Hayes I, Neas K, Stiles M, Graham M, Donoghue T, Aitken A, Skinner J. Detection of sudden death syndromes in New Zealand. NZ Med J. 2016;129:67-74.

14. Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J Arrhythm. 2016; 32:1-28, Heart Rhythm. 2016; 13:e50-86, Europace. 2016; 18:159-183.

15. Waddell-Smith KE, Donoghue T, Oates S, Graham A, Crawford J, Stiles MK, Aitken A, Skinner JR. Inpatient detection of cardiac-inherited disease: the impact of improving family history taking. Open Heart. 2016; 3: e000329

16. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D’Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Van Wagoner DR, Nattel S; Document Reviewers: Centurion OA, Kuck KH, Patton KK, Sapp JL, Stiles M, Svendsen JH, Upadhyay GA, Shantsila A. EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. J Arrhythm. 2016;32:247-78

17. Zhao J, Kharche SR, Hansen BJ, Csepe TA, Wang Y, Stiles MK, Fedorov VV Optimization of catheter ablation of atrial fibrillation: insights gained from clinically-derived computer models. Int J Mol Sci. 2015; 16:10834-54

18. McLellan AJ, Ling LH, Azzopardi S, Lee GA, Lee G, Kumar S, Wong MC, Walters TE, Lee JM, Looi KL, Halloran K, Stiles MK, Lever NA, Fynn SP, Heck PM, Sanders P, Morton JB, Kalman JM, Kistler PM. A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: a prospective multi-centre randomized controlled trial (the Minimax study). Eur Heart J. 2015; 36:1812-21

19. Lau DH, Middeldorp ME, Brooks AG, Ganesan AN, Roberts-Thomson KC, Stiles MK, Leong DP, Abed HS, Lim HS, Wong CX, Willoughby SR, Young GD, Kalman JM, Abhayaratna WP, Sanders P. Aortic stiffness in lone atrial fibrillation: a novel risk factor for arrhythmia recurrence. PLoS One. 2013; 8:e76776.

20. Webber MR, Allen RF, Stiles MK. Unheralded failure of Riata defibrillator lead identified at defibrillation threshold testing. J Arrhythmia 2013; 29:187-189

21. Ogawa S, Aonuma K, Tse H-F, Huang D, Huang J-L, Kalman J, Kamakura S, Nair M, Shin D-G, Stiles M, Teo WS, Yamane T. The APHRS’s 2013 statement on antithrombotic therapy of patients with nonvalvular atrial fibrillation. J Arrhythmia 2013; 29:190-200

22. Webber MR, Levings SL, Stiles MK. Pacing-dependency following implantable cardioverter-defibrillator shocks: a case report. J Electrocardiol 2013; 46:142

23. Earle N, Crawford J, Smith W, Hayes I, Shelling A, Hood M, Stiles M, Maxwell F, Heaven D, Love DR, Skinner JR. Community detection of long QT syndrome with a clinical registry: an alternative to ECG screening programs? Heart Rhythm 2013; 10:233-8

24. Webber MR, Stiles MK, Pasupati S. Percutaneous repair of aortic puncture with Amplatzer closure device during attempted transseptal puncture. J Invasive Cardiol 2013; 25:E110-3

25. Swampillai J, Stiles MK. Hazards of modern pacemaker programming: less is more. J Electrocardiol 2013; 46:140-1

26. Namboodiri N, Stiles MK, Young GD, Sanders P. Electrophysiological features of atrial flutter in cardiac sarcoidosis: a report of two cases. Indian Pacing Electrophysiol J 2012; 12:284-9

27. Webber MR, Stiles MK. Recommendations for the Programming of Cardioverter-Defibrillators in New Zealand. Heart Lung Circ 2012; 21:765-77

28. Ogawa S, Aonuma K, Huang D, Huang J, Kalman J, Kamakura S, Nair M, Shin D, Stiles M, Teo W, Tse H, Yamane T. Fact-finding survey of antithrombotic treatment for prevention of cerebral and systemic thromboembolism in patients with non-valvular atrial fibrillation in 9 countries of the Asia-Pacific region. J Arrhythmia 2012;28:41-5

29. Wilson D, Harding SA, Melton I, Lever NA, Stiles MK, Boddington D, Heald SC, Larsen PD. Geographic, Ethnic and Socioeconomic Factors Influencing Access to Implantable Cardioverter Defibrillators (ICDs) in New Zealand. Heart Lung Circ 2012; 21:576-581

30. Sy RW, Thiagalingam A, Stiles MK. Modern Electrophysiology Mapping Techniques. Heart Lung Circ 2012; ;21:364-375

More publications available upon request.

View More

Presentations

  • October 2018 Asia Pacific Heart Rhythm Society, Taiwan: Invited talk: “The Reversal Agents for NOACs”
  • October 2018 Asia Pacific Heart Rhythm Society, Taiwan: Session Chair: Clinical Science Oral Presentations
  • October 2018 Asia Pacific Heart Rhythm Society, Taiwan: Session Chair: Live Demonstration (Device)  Session Chair: Learning from the Experts
  • May 2018 Heart Rhythm Society, Boston, MA, USA: Invited talk: “Highlights of the HRS ICD programming consensus statement”
  • May 2018 Heart Rhythm Society, Boston, MA, USA: Session Chair: Atrial Tachycardia After AF Ablation October 2018 Asia-Pacific Heart Rhythm Society, Taiwan
  • September 2017 Asia-Pacific Heart Rhythm Society, Japan: Oral presentation: Safety and Efficacy of a Novel Active Fixation Temporary Pacing Lead; First Human Experience”
  • September 2017 Asia-Pacific Heart Rhythm Society, Japan: Judge: Young Investigator Award, Clinical
  • September 2017 Asia-Pacific Heart Rhythm Society, Japan: Session Chair: Device Selection for Primary Prevention of Sudden Cardiac Death, ICD Versus S-ICD
  • September 2017 Asia-Pacific Heart Rhythm Society, Japan: Session Chair: Occlusion of the Left Atrial Appendage Is Preferable to Anticoagulation to Prevent Stroke in Atrial Fibrillation Patients
  • February 2017 Cardiorhythm, Hong Kong: Invited talk: “Idarucizumab: Clinical scenarios and the REVERSE-AD Trial”
  • February 2017 Cardiorhythm, Hong Kong: Invited talk: “Subcutaneous defibrillator: from clinical trials to reality”
  • February 2017 Cardiorhythm, Hong Kong: Invited talk: “Programming ICD parameters to improve outcomes” June 2017 Cardiac Society of Australia and New Zealand, ASM (NZ)
  • February 2017 Cardiorhythm, Hong Kong: Invited talk: “Investigation of Sudden Cardiac Death”
  • November 2016 Asia-Pacific Heart Rhythm Society, South Korea: Invited talk: “Idarucizumab: First Insights in Practice from RE-VERSE AD”
  • November 2016 Asia-Pacific Heart Rhythm Society, South Korea: Session Chair: Device case presentation
  • November 2016 Asia-Pacific Heart Rhythm Society, South Korea: Judge: Young Investigator Award, Clinical
  • November 2016 Asia-Pacific Heart Rhythm Society, South Korea: Session Chair: AF Symposium – Innovations in AF Management and Treatment
  • November 2016 Asia-Pacific Heart Rhythm Society, South Korea: Session Chair: Sports and Arrhythmia
  • August 2016 Cardiac Society of Australia and New Zealand, ASM: Invited talk: “Selecting patients for the S-ICD – dos and don’ts?”
  • June 2016 Cardiac Society of Australia and New Zealand, ASM (NZ): Invited talk: “Device therapy in heart failure”
  • June 2016 Cardiac Society of Australia and New Zealand, ASM (NZ):Invited talk: “Ablation for Everyone! Bringing NZ to Global Intervention Rates”
  • June 2016 Cardiac Society of Australia and New Zealand, ASM (NZ):Invited talk: “International ICD programming guidelines”
  • May 2016 Heart Rhythm Society, San Francisco, CA, USA: Invited talk: “Optimal Tachycardia Detection Parameters for ICD Patients”
  • May 2016 Heart Rhythm Society, San Francisco, CA, USA: Panel member: Webinar “ICD Programming”
  • November 2015 Asia-Pacific Heart Rhythm Society, Australia: Session Chair: Channelopathies and Sudden Cardiac Death
View More

Videos

Accessibility to Community AEDs
Patient Story - Atrial Fibrillation
Atrial Fibrillation Ablation